PMC:7558914 / 22174-22289
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"530","span":{"begin":21,"end":43},"obj":"Gene"},{"id":"542","span":{"begin":0,"end":11},"obj":"Chemical"}],"attributes":[{"id":"A530","pred":"tao:has_database_id","subj":"530","obj":"Gene:3570"},{"id":"A542","pred":"tao:has_database_id","subj":"542","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tocilizumab, an anti-interleukin 6 receptor antibody, has been used in small studies with early reports of success."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T143","span":{"begin":0,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab, an anti-interleukin 6 receptor antibody, has been used in small studies with early reports of success."}